Tribe, Drugmaker Ask Justices To Overturn Bar On Sovereign Immunity IPR Protection
WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals’ ruling that an Indian tribe’s sovereign immunity cannot shield a drug company from inter partes review (IPR) of patents should be...To view the full article, register now.
Already a subscriber? Click here to view full article